Program aims to improve access, outcomes for high-risk patients
BY SHARON WORCESTER
Hospital admissions among those patients decreased from a total of 52 to 36 during the same time period, and total hospital days decreased from 231 to 159, said Dr. Anandarajah, a rheumatologist and director of the Early Arthritis Clinic at the University of Rochester (N.Y.) Medical Center.
In this video interview he discusses the need for, challenges of, and benefits of IQ-LUPUS, along with tips for successful implementation at other centers and thoughts on the feasibility and potential cost savings of the program.
“We have done the math for them,” he said, explaining that not only is there a “huge benefit for patients,” but the potential savings for hospitals is substantial.
Dr. Anandarajah reported having no disclosures.
Sharon Worcester is a reporter with MDedge News.